Clinical trial Recruiting at 2 sites Phase 3 Interventional Ages 18 and up

Ambulance-delivered treatment for suspected stroke

Official title: An Investigator Initiated and Conducted, Prospective, Multicentre, Randomised Outcome-blinded Study of Pre-hospital Initiated Levetiracetam and Headposition in Patients With Presumed Acute Stroke

Run by Shanghai East Hospital · NCT06773364 · Data updated 2026-11-12

This study tests if giving a medication called levetiracetam and adjusting head positions to stroke patients in the ambulance can help them recover better than standard care.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2423 (estimated)
SponsorShanghai East Hospital
Academic / other
Locations2 sites (Suzhou, Anhui and 1 other locations)
StatusRecruiting
StartedApril 30, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedMay 22, 2025
Trial IDNCT06773364 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who show symptoms of an acute stroke within 2 hours of last being well.

Probably not a fit

Patients who are in a coma, have severe co-morbid diseases, or have contraindications to levetiracetam will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the effects of administering levetiracetam and different head positions to patients with suspected acute stroke while they are still in the ambulance. It is a multicenter, randomized controlled trial involving 2323 patients across approximately 50 hospitals in China. Participants will receive either levetiracetam or standard care, and their functional outcomes will be assessed 90 days after treatment. The study aims to determine if these interventions can improve recovery outcomes for stroke patients.

Why it matters

Potential benefit: If successful, this approach could lead to improved functional outcomes for patients experiencing acute strokes.

How similar studies have gone: While similar approaches have been explored, this specific intervention combining ambulance-delivered levetiracetam and head positioning is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults (age ≥18 years);
* Acute condition that is presumed due to acute stroke, defined on the FAST (Face, Arm, Speech, Time) screen (score ≥2 with an arm deficit);
* Time ≤2 hours from last seen well;
* Able to provide brief consent (if a waver of consent not approved by ethics committee).

Exclusion Criteria:

* coma (no response to painful stimulation);
* severe co-morbid disease (e.g. cancer, chronic airflow disease, severe dementia, severe heart failure, pre-existing disability \[needing help with everyday activities\]);
* history of epilepsy or seizure at onset;
* recent head injury;
* hypoglycaemia (glucose \<2.8mmol/L);
* clear indications or contraindications (allergies) for levetiracetam;
* lactating women;
* clear indications for a particular head position or situations where either head position cannot be maintained (such as severe vomiting and inability to lie down, severe obesity with fatigue and difficulty sitting up, etc.).

Where it's running

  • Si County People's Hospital
    Suzhou, Anhui, China
    Recruiting
  • Shanghai East Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Gang Li, PhD, MD — Tongji University, School of Medicine, Shanghai East Hospital
  • Study coordinator: Gang Li, PhD, MD
  • Email: ligang@tongji.edu.cn
  • Phone: 86 13621691786

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.